SEC 13F Intelligence

Managers / Q3 2022 · view latest →

Lion Point Capital, LP

CIK 0001643354 · 375 PARK AVE, SUITE 2609, NEW YORK, NY, 10152 · 212-356-6200

Reported Value
$454M
Q3 2022
Positions
41
Filings on Record
31
2019–present window
Filed
Nov 14, 2022
original filing

Summary

Lion Point Capital, LP reported $454M in U.S.-listed holdings across 41 positions for Q3 2022.

Its largest position, CHRD, represents 7.4% of the portfolio.

Compared with Q2 2022, the fund opened 8 new positions and exited 6.

Portfolio Metrics

Turnover
+12.9%
vs prior filed quarter
Top-10 Concentration
+39.2%
share of reported value
Largest Position
+7.4%
Chord Energy Corporation
New / Exited
8 / 6
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $636MQ4 ’18Q1 ’19: $1.1BQ2 ’19: $1.0BQ3 ’19: $897MQ4 ’19: $1.1BQ4 ’19Q1 ’20: $379MQ2 ’20: $412MQ3 ’20: $456MQ4 ’20: $519MQ4 ’20Q1 ’21: $550MQ2 ’21: $579MQ3 ’21: $533MQ4 ’21: $373MQ4 ’21Q1 ’22: $431MQ2 ’22: $878MQ3 ’22: $454MQ4 ’22: $703MQ4 ’22Q1 ’23: $243MQ2 ’23: $221MQ3 ’23: $224MQ4 ’23: $200MQ4 ’23Q1 ’24: $179MQ2 ’24: $55MQ3 ’24: $45MQ4 ’24: $19MQ4 ’24Q1 ’25: $16MQ2 ’25: $15MQ3 ’25: $18MQ4 ’25: $19MQ4 ’25Q1 ’26: $17Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 56.9%ETP: 39.6%Other: 2.7%US DOMESTIC: 0.7%
  • Common Stock · 56.9% · $258M
  • ETP · 39.6% · $180M
  • Other · 2.7% · $12M
  • US DOMESTIC · 0.7% · $3M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ISHARES TRNEW+600.0K600.0K+$21M$21M
USFDUS FOODS HLDG CORPNEW+350.0K350.0K+$9M$9M
NVDANVIDIA CORPORATIONNEW+30.0K30.0K+$4M$4M
MIRMMIRUM PHARMACEUTICALS INCNEW+80.0K80.0K+$2M$2M
BLUBELLUS HEALTH INC NEWNEW+150.0K150.0K+$1M$1M
CYMABAY THERAPEUTICS INCNEW+219.4K219.4K+$704,000$704,000
ARDXARDELYX INCNEW+550.0K550.0K+$666,000$666,000
MSFTMICROSOFT CORPNEW+100100+$23,000$23,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2022

31 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CHRDCHORD ENERGY CORPORATIONhistory →COM NEW7.40%$34M250.5K
2WTWISDOMTREE INVTS INChistory →COM5.85%$27M4.52M
3EXECHESAPEAKE ENERGY CORPhistory →COM4.27%$19M209.3K
4MARINUS PHARMACEUTICALS INCCOM NEW4.18%$19M3.68M
50LSBURGERFI INTERNATIONAL INChistory →COM3.89%$18M2.75M
6OPTUALTICE USA INChistory →CL A3.22%$15M1.57M
7CIVICIVITAS RESOURCES INChistory →COM NEW3.13%$14M230.0K
8CTIC1USDCTI BIOPHARMA CORPhistory →COM2.57%$12M4.39M
9MISTMILESTONE PHARMACEUTICALS INhistory →COM2.46%$11M1.56M
10ERFGBPENERPLUS CORPhistory →COM2.27%$10M875.0K
11PDCEUSDPDC ENERGY INChistory →COM1.98%$9M130.4K
121T7TRICIDA INChistory →COM1.92%$9M1.37M
13ARCONIC CORPORATIONCOM1.86%$8M812.4K
14DRRXEURDURECT CORPhistory →COM1.73%$8M14.28M
15IM8NINSMED INChistory →COM PAR $.011.68%$8M397.2K
16OVVOVINTIV INChistory →COM1.20%$5M90.0K
17KINIKSA PHARMACEUTICALS LTDCOM CL A1.13%$5M480.0K
18BATLBATTALION OIL CORPCOM0.85%$4M352.9K
19IQIYI INCNOTE 4.000%12/10.74%$3M4.00M
20MCRB1EURSERES THERAPEUTICS INCCOM0.71%$3M626.8K
21MIRMMIRUM PHARMACEUTICALS INCCOM0.38%$2M80.0K
22BLUBELLUS HEALTH INC NEWCOM NEW0.31%$1M150.0K
23ORIGIN MATERIALS INCCOM0.22%$1M100.0K
24LUMOS PHARMA INCCOM0.16%$732,00051.2K
25CYMABAY THERAPEUTICS INCCOM0.16%$704,000219.4K
26ARDXARDELYX INCCOM0.15%$666,000550.0K
27SDIGSTRONGHOLD DIGITAL MINING INCLASS A COM0.08%$380,00020.0K
28OPHTEURIVERIC BIO INCCOM0.06%$284,00029.5K
29SCOR1EURCOMSCORE INCCOM0.01%$25,0001.0K
30MSFTMICROSOFT CORPCOM0.01%$23,000100
31SWCHFSIERRA WIRELESS INCCOM0.00%$3,000100

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$17M35May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$19M39Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$18M27Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$15M19Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$16M21May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$19M19Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$45M25Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$55M27Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$179M32May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$200M30Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$224M31Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$221M30Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$243M31May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$703M32Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$454M41Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$878M40Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$431M35May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$373M33Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$533M38Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$579M34Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$550M30May 19, 2021RESTATEMENTchanges · EDGAR ↗
Q4 2020$519M24Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$456M24Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$412M24Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$379M25May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.1B26Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$897M26Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.0B24Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.1B24May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$636M35Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.